Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Imaging Glia-mediated NeuroInflammation and Treatment Efficacy (the IGNITE Study)

NCT03106740 is registered in ClinicalTrials.gov with Marco Loggia as lead sponsor.

NCT NCT03106740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03106740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Imaging Glia-mediated NeuroInflammation and Treatment Efficacy (the IGNITE Study)
Lead sponsor
Marco Loggia
Phase
Phase 2
Overall status
Completed
Start date
October 10, 2017
Completion date
April 30, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

back ache, back pain lower back chronic, back pain with radiation, back pain without radiation, low back pain, pain, chronic